中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
10期
447
,共1页
心率变异性%HRVI%SpO2%瑞芬太尼%麻醉检测
心率變異性%HRVI%SpO2%瑞芬太尼%痳醉檢測
심솔변이성%HRVI%SpO2%서분태니%마취검측
Heart rate variability%HRVI%SpO2%Remifentanil%Narcotic detection
目的探讨分析心率变异性测定在麻醉监测中的应用.方法我院在2011年8月至2012年2月期间共接诊100例需要进行短小手术患儿,均使用瑞芬太尼进行全麻,观察分析患儿在T0(术前)、T1(诱导后)、T2(置入喉罩)、T3(切皮)、T4(术毕)、T5(拔出喉罩5min)内的LF/HF(低频/高频)、HRVI(心率变异指数)、HR(心率)、SpO2(脉氧饱和度)等变化情况.结果 T1-T4期间LF/HF(低频/高频)、HRVI(心率变异指数)、HR(心率)明显低于T0时值,差异显著具有统计学意义(P<0.05),而T1-T4各项指标均无明显差异,并且T5与T0相比也无明显差异,基本保持平稳,则无统计学意义(P>0.05).而SpO2(脉氧饱和度)在整个麻醉过程中均保持在98%以上无显著性差异,无统计学意义(P>0.05).结论在小儿全麻中使用瑞芬太尼,可有效的保证血液动力学的平稳,采取心率变异性测定可有效地对麻醉过程进行监测,应大力推广应用.
目的探討分析心率變異性測定在痳醉鑑測中的應用.方法我院在2011年8月至2012年2月期間共接診100例需要進行短小手術患兒,均使用瑞芬太尼進行全痳,觀察分析患兒在T0(術前)、T1(誘導後)、T2(置入喉罩)、T3(切皮)、T4(術畢)、T5(拔齣喉罩5min)內的LF/HF(低頻/高頻)、HRVI(心率變異指數)、HR(心率)、SpO2(脈氧飽和度)等變化情況.結果 T1-T4期間LF/HF(低頻/高頻)、HRVI(心率變異指數)、HR(心率)明顯低于T0時值,差異顯著具有統計學意義(P<0.05),而T1-T4各項指標均無明顯差異,併且T5與T0相比也無明顯差異,基本保持平穩,則無統計學意義(P>0.05).而SpO2(脈氧飽和度)在整箇痳醉過程中均保持在98%以上無顯著性差異,無統計學意義(P>0.05).結論在小兒全痳中使用瑞芬太尼,可有效的保證血液動力學的平穩,採取心率變異性測定可有效地對痳醉過程進行鑑測,應大力推廣應用.
목적탐토분석심솔변이성측정재마취감측중적응용.방법아원재2011년8월지2012년2월기간공접진100례수요진행단소수술환인,균사용서분태니진행전마,관찰분석환인재T0(술전)、T1(유도후)、T2(치입후조)、T3(절피)、T4(술필)、T5(발출후조5min)내적LF/HF(저빈/고빈)、HRVI(심솔변이지수)、HR(심솔)、SpO2(맥양포화도)등변화정황.결과 T1-T4기간LF/HF(저빈/고빈)、HRVI(심솔변이지수)、HR(심솔)명현저우T0시치,차이현저구유통계학의의(P<0.05),이T1-T4각항지표균무명현차이,병차T5여T0상비야무명현차이,기본보지평은,칙무통계학의의(P>0.05).이SpO2(맥양포화도)재정개마취과정중균보지재98%이상무현저성차이,무통계학의의(P>0.05).결론재소인전마중사용서분태니,가유효적보증혈액동역학적평은,채취심솔변이성측정가유효지대마취과정진행감측,응대력추엄응용.
Objective To investigate the analysis of heart rate variability during anesthesia monitoring application. Methods In our hospital in 2011 August to 2012 February a total of 100 cases during the reception operation in children need for short, are the use of remifentanil for general anesthesia, observation and analysis in children with T0 (preoperative), T1 (induced), T2 (inserting the laryngeal mask airway), T3 (skin), T4 (surgery), T5 (pull a laryngeal mask for 5 minutes) of LF/HF (LF/HF), HRVI (heart rate variability index (HR), heart rate (SpO2), pulse oxygen saturation ) changes. Results T1-T4 LF/HF(LF/HF), HRVI ( heart rate variability index ), HR (heart rate ) was significantly lower than that of T0 duration, difference has statistical significance (P<0.05), and T1-T4 indicators showed no significant difference compared with T0 and T5, and there were no significant differences in the stable, no statistical significance (P>0.05). While SpO2 ( pulse oxygen saturation ) in the anesthesia process have remained at more than 98%no significant difference, no statistical significance (P>0.05). Conclusion In pediatric general anesthesia using remifentanil, can effectively guarantee the stable hemodynamics, adopt measure of heart rate variability can be effectively monitored anesthesia process, should popularize application energetically.